Evaluation of ST2 and NT-proBNP as cardiac biomarkers in dogs with heartworm disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
This study compared serum concentrations of suppression of tumorigenicity 2 (ST2) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) between healthy and heartworm- infected dogs. Eighteen heartworm-infected dogs and five healthy dogs were included in the study. Dogs were diagnosed and categorized by history, clinical signs, and blood assay, thoracic radiography, echocardiography, and com-mercial ELISA kit results. Serum samples were sent to the IDEXX reference laboratory for NT-proBNP measurement. ST2 was examined by using a canine interleukin 33 receptor ELISA kit with the quantita-tive sandwich ELISA method. The severely infected group showed significant elevation of NT-proBNP concentration over those of the control (P=0.03) and mildly infected (P=0.04) group. There were no significant difference in ST2 concentrations among the three groups. The usefulness of NT-proBNP as a cardiac biomarker in dogs with severe heartworm disease was confirmed by the results of this study. Further investigations to assess ST2 as a cardiac biomarker are warranted.
Abstract
This study compared serum concentrations of suppression of tumorigenicity 2 (ST2) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) between healthy and heartworm- infected dogs. Eighteen heartworm-infected dogs and five healthy dogs were included in the study. Dogs were diagnosed and categorized by history, clinical signs, and blood assay, thoracic radiography, echocardiography, and com-mercial ELISA kit results. Serum samples were sent to the IDEXX reference laboratory for NT-proBNP measurement. ST2 was examined by using a canine interleukin 33 receptor ELISA kit with the quantita-tive sandwich ELISA method. The severely infected group showed significant elevation of NT-proBNP concentration over those of the control (P=0.03) and mildly infected (P=0.04) group. There were no significant difference in ST2 concentrations among the three groups. The usefulness of NT-proBNP as a cardiac biomarker in dogs with severe heartworm disease was confirmed by the results of this study. Further investigations to assess ST2 as a cardiac biomarker are warranted.
참고문헌 (18)
- "Guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs"[URL]
- Atkinson AJ, "Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework", Clin Pharmacol Ther, 69, pp.89~95 (2001)[DOI]
- Bayes-Genis A, "Combined use of high‐sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure", Eur J Heart Fail, 14, pp.32~38 (2012)[DOI]
- Boswood A, "Biomarkers in cardiovascular disease: Beyond natriuretic peptides", J Vet Cardiol, 11, pp.S23~S32 (2009)[DOI]
- Braunwald E, "Biomarkers in heart failure", N Engl J Med, 358, pp.2148~2159 (2008)[DOI]
- Carreton E, "Dirofilaria immitis infection in dogs: Cardiopulmonary biomarker levels", Vet Parasitol, 176, pp.313~316 (2011)[DOI]
- Carreton E, "Cardiopulmonary and in- flammatory biomarkers in the assessment of the severity of canine dirofilariasis", Vet Parasitol, 206, pp.43~47 (2014)[DOI]
- Di Sacco B, "Clinical classification of heartworm disease for the purpose of adding objectivity to the assessment of therapeutic efficacy of adulticidal drugs in the field", Proceedings of the Heartworm Symposium'92, pp.209~214 (1992), American Heartworm Society
- Ebisawa T, "Clinical use of n-terminal pro-brain natriuretic peptide concentrations for assessing the severity and prognosis of myxomatous mitral valve disease in dogs", Intern J Appl Res Vet Med, 10, pp.234~242 (2012)
- Ettinger SJ, "Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease", J Am Vet Med Assoc, 240, pp.171~180 (2012)[DOI]
- Kelihan HB, "Weekly variability of plasma and serum NT-proBNP measurements in normal dogs", J Vet Cardiol, 11, pp.S93~S97 (2009)[DOI]
- Oyama MA, "Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity", J Am Vet Med Assoc, 232, pp.1496~1503 (2008)[DOI]
- Piper S, "Biologic variability of soluble ST2 in patients with stable chronic heart failure and implications for monitoring", Am J Cardiol, 118, pp.95~98 (2016)[DOI]
- Ruaux C, "Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration", Vet Clin Pathol, 44, pp.420~430 (2015)[DOI]
- Schmidt MK, "Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study", J Vet Cardiol, 11, pp.S81~S86 (2009)[DOI]
- Shah RV, "ST2: a novel remodeling biomarker in acute and chronic heart failure", Curr Heart Fail Rep, 7, pp.9~14 (2010)[DOI]
- Song KH, "Serological update and molecular characterization of Dirofilaria im- mitis in dogs, South Korea", Res Vet Sci, 88, pp.467~469 (2010)[DOI]
- Villacorta H, "Soluble ST2 testing: a promising biomarker in the management of heart failure", Arq Bras Cardiol, 106, pp.145~152 (2016)